Frequently Asked Questions
The biomanufacturing viral detection and quantification market size will be worth USD 970.42 million by 2031.
The growth rate of the biomanufacturing viral detection and quantification market is 9.37%.
Increasing demand for biopharmaceuticals & technological advancements in technologies are the growth drivers of the biomanufacturing viral detection and quantification market.
Offering type, technology, application, and end user are the factors on which the biomanufacturing viral detection and quantification market research is based.
Major companies in the biomanufacturing viral detection and quantification market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Sartorius AG (Germany), Charles River Laboratories (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), QIAGEN (Netherlands), Lonza Group Ltd. (Switzerland), Pall Corporation (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.S.), Roche Diagnostics International Ltd. (Switzerland), BD (U.S.), Promega Corporation (U.S.), FUJIFILM Diosynth Biotechnologies (U.S.), Avantor, Inc. (U.S.), SGS Societe Generale de Surveillance SA. (Switzerland), Eurofins Scientific (Luxembourg), Virapur LLC (U.S.), BioReliance Corporation (U.S.).
